SAN FRANCISCO, June 17 /PRNewswire/ -- The New York Stem Cell Foundation (NYSCF), which has supported more than 23 outstanding young stem cell scientists through its Post-Doctoral Fellowship Program, today announced a significant expansion of its efforts to cultivate the next generation of stem cell scientists by providing $24.5 million in funding to 17 Investigators to launch their own laboratories, train other scientists, and foster innovative high-risk/high-reward research to explore the therapeutic potential of stem cells derived from humans and model organisms.
/C O R R E C T I O N -- Shenzhen Beike Biotechnology Co. Ltd./
In the news release, "Beike Biotech Launches New International Stem Cell
Venture," issued earlier today by Shenzhen Beike Biotechnology Co. Ltd. over
PR Newswire, we are advised by the company that the first sentence of the
second paragraph should read, "Beike's stem cells have been shown to be safe
and effective in therapies based on direct clinical observation in the
hospital setting," rather than, "In China, Beike's use of cord blood and
tissue-derived stem cells is approved by the Chinese Ministry of Health as a
Class 3 medical therapy for numerous clinical applications," as originally
issued inadvertently.
Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility
TAIZHOU, China, May 11 /PRNewswire-Asia/ -- Beike Biotechnology Co. Ltd.,
one of the world's leading biotechnology companies focusing on adult stem cell
therapies, and the Jiangsu government's China Medical City (CMC) opened
China's state-of-the-art stem cell storage and processing facility today.
